Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Heyn H"" wg kryterium: Autor


Wyświetlanie 1-14 z 14
Tytuł:
Single human oocyte transcriptome analysis reveals distinct maturation stage-dependent pathways impacted by age.
Autorzy:
Llonch S; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Barragán M; Clínica EUGIN, Barcelona, Spain.
Nieto P; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Mallol A; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Elosua-Bayes M; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Lorden P; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Ruiz S; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Zambelli F; Clínica EUGIN, Barcelona, Spain.
Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Vassena R; Clínica EUGIN, Barcelona, Spain.
Payer B; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2021 May; Vol. 20 (5), pp. e13360. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Transcriptome*
Aging/*genetics
Oocytes/*metabolism
Adolescent ; Adult ; Body Mass Index ; Female ; Gene Expression Regulation ; Humans ; Oocytes/growth & development ; RNA-Seq ; Single-Cell Analysis ; Young Adult
Czasopismo naukowe
Tytuł:
Characterization and Genomic Study of the Novel Bacteriophage HY01 Infecting Both Escherichia coli O157:H7 and Shigella flexneri: Potential as a Biocontrol Agent in Food.
Autorzy:
Lee H; Department of Food Science and Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Yongin, Republic of Korea.
Ku HJ; Department of Food Science and Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Yongin, Republic of Korea.
Lee DH; Department of Food Science and Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Yongin, Republic of Korea.
Kim YT; Department of Food Science and Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Yongin, Republic of Korea.
Shin H; Department of Food and Animal Biotechnology, Department of Agricultural Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea.; Faculty of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul, Republic of Korea.
Ryu S; Department of Food and Animal Biotechnology, Department of Agricultural Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea.
Lee JH; Department of Food Science and Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Yongin, Republic of Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Dec 30; Vol. 11 (12), pp. e0168985. Date of Electronic Publication: 2016 Dec 30 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Biological Control Agents/*pharmacology
Dysentery, Bacillary/*prevention & control
Escherichia coli Infections/*prevention & control
Escherichia coli O157/*virology
Food Preservatives/*pharmacology
Foodborne Diseases/*prevention & control
Myoviridae/*growth & development
Shigella flexneri/*virology
Animals ; Dysentery, Bacillary/microbiology ; Escherichia coli Infections/microbiology ; Escherichia coli O157/genetics ; Feces/microbiology ; Food Microbiology ; Foodborne Diseases/microbiology ; Genome, Viral/genetics ; Host Specificity ; Myoviridae/genetics ; Proteomics ; Shigella flexneri/genetics ; Swine
Czasopismo naukowe
Tytuł:
Cancer network activity associated with therapeutic response and synergism.
Autorzy:
Serra-Musach J; Breast Cancer and Systems Biology Lab, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Mateo F; Breast Cancer and Systems Biology Lab, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Capdevila-Busquets E; Joint IRB-BSC-CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Catalonia, Spain.
de Garibay GR; Breast Cancer and Systems Biology Lab, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Zhang X; Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Dr. Rockville, Bethesda, MD, 20850, USA.
Guha R; Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Dr. Rockville, Bethesda, MD, 20850, USA.
Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Dr. Rockville, Bethesda, MD, 20850, USA.
Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Cellex Center, Natzaret 115-117, Barcelona, 08035, Catalonia, Spain.
Villanueva A; Breast Cancer and Systems Biology Lab, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Jaeger S; Joint IRB-BSC-CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Catalonia, Spain.
Heyn H; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Vizoso M; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Pérez H; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Cordero A; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Gonzalez-Suarez E; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Esteller M; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Feixa Llarga s/n, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, Barcelona, 08010, Catalonia, Spain.
Moreno-Bueno G; Department of Biochemistry, Autonomous University of Madrid (UAM), Biomedical Research Institute 'Alberto Sols' (Spanish National Research Council (CSIC)-UAM), Hospital La Paz Institute for Health Research (IdiPAZ), Arzobispo Morcillo 4, Madrid, 28029, Spain.; MD Anderson International Foundation, Arturo Soria 270, Madrid, 28033, Spain.
Tjärnberg A; The Centre for Individualized Medicine, Department of Clinical and Experimental Medicine, Linköping University, Linköping, 58183, Sweden.
Lázaro C; Hereditary Cancer Program, ICO, IDIBELL, Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain.
Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Cellex Center, Natzaret 115-117, Barcelona, 08035, Catalonia, Spain.
Arribas J; Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, Barcelona, 08010, Catalonia, Spain.; Preclinical Research Program, VHIO, Cellex Center, Natzaret 115-117, Barcelona, 08035, Catalonia, Spain.; Department of Biochemistry and Molecular Biology, Medical School Building M, Autonomous University of Barcelona, Bellaterra, 08193, Catalonia, Spain.
Benson M; The Centre for Individualized Medicine, Department of Clinical and Experimental Medicine, Linköping University, Linköping, 58183, Sweden.
Gustafsson M; The Centre for Individualized Medicine, Department of Clinical and Experimental Medicine, Linköping University, Linköping, 58183, Sweden.
Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Dr. Rockville, Bethesda, MD, 20850, USA. .
Aloy P; Joint IRB-BSC-CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Catalonia, Spain. .; Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys 23, Barcelona, 08010, Catalonia, Spain. .
Pujana MÀ; Breast Cancer and Systems Biology Lab, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona, 08908, Catalonia, Spain. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2016 Aug 24; Vol. 8 (1), pp. 88. Date of Electronic Publication: 2016 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacology
Drugs, Investigational/*pharmacology
Gene Expression Regulation, Neoplastic/*drug effects
Gene Regulatory Networks/*drug effects
Neoplasm Proteins/*genetics
Prescription Drugs/*pharmacology
Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Survival/drug effects ; Drug Synergism ; Female ; Gene Expression Profiling ; Gene Ontology ; Humans ; Molecular Sequence Annotation ; Mutation ; Neoplasm Proteins/metabolism ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Signal Transduction ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Tytuł:
Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer.
Autorzy:
Heyn H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2016 Mar 03; Vol. 12 (3), pp. e1005826. Date of Electronic Publication: 2016 Mar 03 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Genome-Wide Association Study*
Neoplasms/*genetics
Quantitative Trait Loci/*genetics
Regulatory Sequences, Nucleic Acid/*genetics
DNA Methylation/genetics ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Humans ; Neoplasms/pathology ; Open Reading Frames/genetics ; Polymorphism, Single Nucleotide/genetics
Czasopismo naukowe
Tytuł:
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.
Autorzy:
Vizoso M; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Ferreira HJ; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Lopez-Serra P; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Carmona FJ; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Martínez-Cardús A; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Girotti MR; Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK.
Villanueva A; Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Guil S; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Moutinho C; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Liz J; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Portela A; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Heyn H; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Moran S; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Vidal A; Department of Pathological Anatomy, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Martinez-Iniesta M; Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Manzano JL; Medical Oncology Service, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain.
Fernandez-Figueras MT; Pathology Department, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain.
Elez E; Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain.
Muñoz-Couselo E; Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain.
Botella-Estrada R; Dermatology Service, Hospital La Fe, Universidad de Valencia, Valencia, Spain.
Berrocal A; Medical Oncology Service, Hospital General, Valencia, Spain.
Pontén F; Department of Pathology, University Hospital of Uppsala, Uppsala, Sweden.
Oord Jv; Translational Cell &Tissue Pathology, Katholieke Universiteit Leuven, Leuven, Belgium.
Gallagher WM; University College Dublin School of Biomolecular and Biomedical Science, University College Dublin Conway Institute, University College Dublin, Belfield, Dublin, Ireland.
Frederick DT; Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Flaherty KT; Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
McDermott U; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Lorigan P; University of Manchester, Christie National Health Service Foundation Trust, Manchester, UK.
Marais R; Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, UK.
Esteller M; 1] Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain. [2] Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. [3] Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain.
Pokaż więcej
Źródło:
Nature medicine [Nat Med] 2015 Jul; Vol. 21 (7), pp. 741-50. Date of Electronic Publication: 2015 Jun 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Progression*
Epigenesis, Genetic*/drug effects
ErbB Receptors/*metabolism
GTPase-Activating Proteins/*genetics
Melanoma/*genetics
Melanoma/*pathology
Animals ; Cell Line, Tumor ; DNA Methylation/drug effects ; DNA Methylation/genetics ; GTPase-Activating Proteins/metabolism ; Immunoprecipitation ; Mice, Nude ; Molecular Weight ; Neoplasm Metastasis ; Prognosis ; Promoter Regions, Genetic/genetics ; Protein Binding/drug effects ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Protein Kinase Inhibitors/pharmacology ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Small Interfering/metabolism ; Signal Transduction/drug effects ; Transcriptional Activation/drug effects ; Transcriptional Activation/genetics ; Treatment Outcome ; rab GTP-Binding Proteins/metabolism
Czasopismo naukowe
Tytuł:
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Autorzy:
Blanco I; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Kuchenbaecker K; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Cuadras D; Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America.
Barrowdale D; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
de Garibay GR; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Librado P; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
Sánchez-Gracia A; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
Rozas J; Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain.
Bonifaci N; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
McGuffog L; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Islam A; Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh.
Mateo F; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Berenguer A; Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Petit A; Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Català I; Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain.
Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Tornero E; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Benítez J; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain.
Osorio A; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain.
Ramón y Cajal T; Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Arun BK; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Toland AE; Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America.
Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America.
Nussbaum RL; Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America.
Andrulis IL; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Domchek SM; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Nathanson KL; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
Rebbeck TR; Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Barkardottir RB; Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Van Maerken T; Center for Medical Genetics, Ghent University, Ghent, Belgium.
Díez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Hansen TV; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Jønson L; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
de la Hoya M; Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain.
Caldés T; Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain.
Dunning AM; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Oliver C; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Fineberg E; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Cook M; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Peock S; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
McCann E; All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom.
Murray A; All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom.
Jacobs C; Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Pichert G; Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Lalloo F; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.
Chu C; Yorkshire Regional Genetics Service, Leeds, United Kingdom.
Dorkins H; North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom.
Paterson J; Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom.
Ong KR; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom.
Teixeira MR; Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.
van der Hout AH; Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Luijt RB; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Ligtenberg MJ; Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Wijnen JT; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Meijers-Heijboer HE; Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands.
Blok MJ; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
van den Ouweland AM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Aalfs CM; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands.
Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America.
Phillips KA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
Piedmonte M; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Nerenstone SR; Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America.
Bae-Jump VL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
O'Malley DM; Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America.
Ratner ES; Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Schmutzler RK; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Wappenschmidt B; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Rhiem K; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Meindl A; Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
Ditsch N; Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany.
Arnold N; Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany.
Plendl HJ; Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany.
Niederacher D; Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Sutter C; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Wang-Gohrke S; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
Preisler-Adams S; Institute of Human Genetics, University of Münster, Münster, Germany.
Kast K; Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Varon-Mateeva R; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany.
Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
Pedersen IS; Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Sunde L; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Peterlongo P; Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy.
Bernard L; Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Scuvera G; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy.
Ottini L; Department of Molecular Medicine, 'Sapienza' University, Rome, Italy.
Montagna M; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
Agata S; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy.
Maugard C; Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
Soucy P; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada.
Berger A; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Fink-Retter A; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Singer CF; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Rappaport C; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Geschwantler-Kaulich D; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Tea MK; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pfeiler G; Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America.
Miron A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Terry MB; Department of Epidemiology, Columbia University, New York, New York, United States of America.
Chung WK; Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania.
Dorfling CM; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
van Rensburg EJ; Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa.
Fostira F; Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece.
Konstantopoulou I; Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece.
Garber J; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America.
Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Narod SA; Women's College Research Institute, University of Toronto, Toronto, Canada.
Rennert G; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel.
Paluch SS; The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Laitman Y; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel.
Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Liljegren A; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
Rantala J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Loman N; Department of Oncology, Lund University Hospital, Lund, Sweden.
Imyanitov EN; N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Spurdle AB; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
Healey S; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
Weitzel JN; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Herzog J; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America.
Margileth D; St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America.
Gorrini C; The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada.
Esteller M; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain.
Gómez A; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Sayols S; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Vidal E; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Heyn H; Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain.
Stoppa-Lyonnet D; Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Léoné M; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France.
Barjhoux L; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Fassy-Colcombet M; Department of Tumour Biology, Institut Curie, Paris, France.
de Pauw A; Department of Tumour Biology, Institut Curie, Paris, France.
Lasset C; Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
Ferrer SF; Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France.
Castera L; Department of Tumour Biology, Institut Curie, Paris, France.
Berthet P; Centre François Baclesse, Caen, France.
Cornelis F; Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France.
Bignon YJ; Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France.
Damiola F; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Mazoyer S; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Sinilnikova OM; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Maxwell CA; Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada.
Vijai J; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Robson M; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Kauff N; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Corines MJ; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Villano D; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Cunningham J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Lee A; Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America.
Lindor N; Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Easton DF; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Offit K; Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Chenevix-Trench G; Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Antoniou AC; Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Pujana MA; Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain.
Pokaż więcej
Corporate Authors:
Teixeira
BCFR
SWE-BRCA
kConFab Investigators
GEMO
Źródło:
PloS one [PLoS One] 2015 Apr 01; Vol. 10 (4), pp. e0120020. Date of Electronic Publication: 2015 Apr 01 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Genes, BRCA1*
Genes, BRCA2*
Mutation*
Breast Neoplasms/*genetics
Genetic Predisposition to Disease/*genetics
Aurora Kinase A/genetics ; Breast Neoplasms/enzymology ; Breast Neoplasms/pathology ; Carcinogenesis/genetics ; Cell Cycle Proteins/genetics ; Estrogen Receptor alpha/metabolism ; Evolution, Molecular ; Extracellular Matrix Proteins/genetics ; Female ; Genetic Loci/genetics ; Humans ; Hyaluronan Receptors/genetics ; Likelihood Functions ; Mammary Glands, Human/metabolism ; Microtubule-Associated Proteins/genetics ; Nuclear Proteins/genetics ; Polymorphism, Single Nucleotide ; Retrospective Studies ; Tubulin/genetics
Czasopismo naukowe
Tytuł:
The DNA methylation drift of the atherosclerotic aorta increases with lesion progression.
Autorzy:
Valencia-Morales Mdel P; Department of Genetic Engineering, CINVESTAV, Irapuato, Guanajuato, Mexico. .
Zaina S; Department of Medical Sciences, Division of Health Sciences, León Campus, University of Guanajuato, 20 de Enero no. 929, 37320, León, Guanajuato, Mexico. .; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Heyn H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Carmona FJ; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Varol N; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Sayols S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Condom E; Department of Pathology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain. .; Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Catalonia, Spain. .
Ramírez-Ruz J; Department of Anatomic Pathology, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain. .
Gomez A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Moran S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .
Lund G; Department of Genetic Engineering, CINVESTAV, Irapuato, Guanajuato, Mexico. .
Rodríguez-Ríos D; Department of Genetic Engineering, CINVESTAV, Irapuato, Guanajuato, Mexico. .
López-González G; Bachelor's Degree in Nutrition Programme, Division of Health Sciences, León Campus, University of Guanajuato, León, Guanajuato, Mexico. glg_.
Ramírez-Nava M; Bachelor's Degree in Nutrition Programme, Division of Health Sciences, León Campus, University of Guanajuato, León, Guanajuato, Mexico. .
de la Rocha C; Department of Genetic Engineering, CINVESTAV, Irapuato, Guanajuato, Mexico. .
Sanchez-Flores A; University DNA Massive Sequencing Unit, Institute of Biotechnology, UNAM, Cuernavaca, Morelos, Mexico. .
Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Vía s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. .; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. .; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Catalonia, Spain. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2015 Feb 27; Vol. 8, pp. 7. Date of Electronic Publication: 2015 Feb 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Aorta/*pathology
Atherosclerosis/*genetics
Atherosclerosis/*pathology
Animals ; Cluster Analysis ; CpG Islands ; Databases, Genetic ; Disease Progression ; Epigenesis, Genetic ; Humans ; Immune System ; Inflammation/pathology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Oligonucleotide Array Sequence Analysis ; Plaque, Atherosclerotic/pathology ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Impaired DICER1 function promotes stemness and metastasis in colon cancer.
Autorzy:
Iliou MS; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
da Silva-Diz V; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Carmona FJ; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Ramalho-Carvalho J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Heyn H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Villanueva A; Laboratory of Translational Research, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Muñoz P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Esteller M; 1] Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain [2] Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain [3] Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2014 Jul 24; Vol. 33 (30), pp. 4003-15. Date of Electronic Publication: 2013 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colonic Neoplasms/*enzymology
DEAD-box RNA Helicases/*physiology
Liver Neoplasms/*enzymology
Neoplastic Stem Cells/*enzymology
Ribonuclease III/*physiology
Animals ; Antigens, Neoplasm/genetics ; Antigens, Neoplasm/metabolism ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinogenesis/metabolism ; Cell Adhesion Molecules/genetics ; Cell Adhesion Molecules/metabolism ; Colonic Neoplasms/pathology ; Epithelial Cell Adhesion Molecule ; Epithelial-Mesenchymal Transition ; Gene Expression Regulation, Neoplastic ; HCT116 Cells ; Humans ; Hyaluronan Receptors/genetics ; Hyaluronan Receptors/metabolism ; Liver Neoplasms/secondary ; Male ; Mice ; Mice, Nude ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Neoplasm Transplantation ; RNA Interference ; Up-Regulation
Czasopismo naukowe
Tytuł:
Global epigenomic reconfiguration during mammalian brain development.
Autorzy:
Lister R; Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.; Plant Energy Biology [Australian Research Council Center of Excellence (CoE)] and Computational Systems Biology (Western Australia CoE), School of Chemistry and Biochemistry, The University of Western Australia, Perth, WA 6009, Australia.
Mukamel EA; Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Nery JR; Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Urich M; Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Puddifoot CA; Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Johnson ND; Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Lucero J; Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Huang Y; La Jolla Institute for Allergy and Immunology and Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA.
Dwork AJ; Department of Psychiatry, Columbia University and The New York State Psychiatric Institute, New York, NY 10032, USA.; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
Schultz MD; Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.; Bioinformatics Program, University of California at San Diego, La Jolla, CA 92093, USA.
Yu M; Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA.
Tonti-Filippini J; Plant Energy Biology [Australian Research Council Center of Excellence (CoE)] and Computational Systems Biology (Western Australia CoE), School of Chemistry and Biochemistry, The University of Western Australia, Perth, WA 6009, Australia.
Heyn H; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08907, Spain.
Hu S; Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Wu JC; Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Rao A; La Jolla Institute for Allergy and Immunology and Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA.
Esteller M; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08907, Spain.; InstitucióCatalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
He C; Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA.
Haghighi FG; Department of Psychiatry, Columbia University and The New York State Psychiatric Institute, New York, NY 10032, USA.
Sejnowski TJ; Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.; Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92037, USA.; Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Behrens MM; Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Ecker JR; Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.; Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2013 Aug 09; Vol. 341 (6146), pp. 1237905. Date of Electronic Publication: 2013 Jul 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
DNA Methylation*
Epigenesis, Genetic*
Gene Expression Regulation, Developmental*
Cytosine/*analogs & derivatives
Frontal Lobe/*growth & development
5-Methylcytosine/metabolism ; Adult ; Animals ; Base Sequence ; Conserved Sequence ; Cytosine/metabolism ; Epigenomics ; Genome-Wide Association Study ; Humans ; Longevity ; Mice ; Mice, Inbred C57BL ; X Chromosome Inactivation/genetics
Czasopismo naukowe
Tytuł:
Dynamics of DNA methylation in recent human and great ape evolution.
Autorzy:
Hernando-Herraez I; Institute of Evolutionary Biology (UPF-CSIC), PRBB, Barcelona, Spain.
Prado-Martinez J
Garg P
Fernandez-Callejo M
Heyn H
Hvilsom C
Navarro A
Esteller M
Sharp AJ
Marques-Bonet T
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2013; Vol. 9 (9), pp. e1003763. Date of Electronic Publication: 2013 Sep 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Epigenesis, Genetic*
Genomic Imprinting*
Promoter Regions, Genetic*
DNA Methylation/*genetics
Animals ; CpG Islands/genetics ; Gene Expression Regulation ; Gorilla gorilla/genetics ; Hominidae/genetics ; Humans ; Pan paniscus/genetics ; Pan troglodytes/genetics ; Pongo/genetics
Czasopismo naukowe
Tytuł:
Inflammatory and oxidative stress responses of an alveolar epithelial cell line to airborne zinc oxide nanoparticles at the air-liquid interface: a comparison with conventional, submerged cell-culture conditions.
Autorzy:
Lenz AG; Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum München, Ingolstaedter Landstrasse 1, 85758 Neuherberg, Germany. />Karg E
Brendel E
Hinze-Heyn H
Maier KL
Eickelberg O
Stoeger T
Schmid O
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2013; Vol. 2013, pp. 652632. Date of Electronic Publication: 2013 Jan 02.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Epithelial Cells/*metabolism
Nanoparticles/*adverse effects
Oxidative Stress/*drug effects
Pulmonary Alveoli/*metabolism
Respiratory Mucosa/*metabolism
Zinc Oxide/*adverse effects
Cell Culture Techniques ; Cell Line, Tumor ; Cell Survival/drug effects ; Cytokines/biosynthesis ; Epithelial Cells/pathology ; Humans ; Inflammation/chemically induced ; Inflammation/metabolism ; Inflammation/pathology ; Inflammation Mediators/metabolism ; Pulmonary Alveoli/pathology ; Respiratory Mucosa/pathology ; Zinc Oxide/pharmacology
Czasopismo naukowe
Tytuł:
DNA methylation profiling in the clinic: applications and challenges.
Autorzy:
Heyn H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
Esteller M
Pokaż więcej
Źródło:
Nature reviews. Genetics [Nat Rev Genet] 2012 Oct; Vol. 13 (10), pp. 679-92. Date of Electronic Publication: 2012 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
DNA Methylation*/physiology
Gene Expression Profiling*/methods
Gene Expression Profiling*/statistics & numerical data
Clinical Laboratory Techniques/*methods
Animals ; Clinical Laboratory Techniques/standards ; Disease/genetics ; Epigenesis, Genetic/physiology ; Humans ; Models, Biological ; Molecular Targeted Therapy/methods ; Molecular Targeted Therapy/trends
Czasopismo naukowe
Tytuł:
Novel insights into DNA methylation features in spermatozoa: stability and peculiarities.
Autorzy:
Krausz C; Department of Clinical Physiopathology, Andrology Unit, University of Florence, Florence, Italy. />Sandoval J
Sayols S
Chianese C
Giachini C
Heyn H
Esteller M
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (10), pp. e44479. Date of Electronic Publication: 2012 Oct 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Spermatozoa/*metabolism
Adult ; CpG Islands ; Databases, Genetic ; Epigenesis, Genetic ; Humans ; Male ; Middle Aged ; RNA, Small Untranslated/metabolism ; Vocabulary, Controlled
Czasopismo naukowe
Tytuł:
Epigenetic disruption of the PIWI pathway in human spermatogenic disorders.
Autorzy:
Heyn H; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
Ferreira HJ
Bassas L
Bonache S
Sayols S
Sandoval J
Esteller M
Larriba S
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (10), pp. e47892. Date of Electronic Publication: 2012 Oct 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Spermatogenesis*
Argonaute Proteins/*genetics
Infertility, Male/*genetics
Spermatozoa/*metabolism
Adult ; Carrier Proteins/genetics ; Cell Cycle Proteins ; DNA/genetics ; Down-Regulation ; Humans ; Infertility, Male/pathology ; Male ; Middle Aged ; RNA/genetics ; Sertoli Cell-Only Syndrome/genetics ; Sertoli Cell-Only Syndrome/pathology ; Spermatozoa/pathology
Czasopismo naukowe
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies